Dietary capsaicin prevents nonalcoholic fatty liver disease through transient receptor potential vanilloid 1-mediated peroxisome proliferator-activated receptor δ activation (Q44206097)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 April 2013

Language	Label	Description	Also known as
English	Dietary capsaicin prevents nonalcoholic fatty liver disease through transient receptor potential vanilloid 1-mediated peroxisome proliferator-activated receptor δ activation	scientific article published on 21 April 2013

Statements

scholarly article

1 reference

Europe PubMed Central

30 November 2017

Dietary capsaicin prevents nonalcoholic fatty liver disease through transient receptor potential vanilloid 1-mediated peroxisome proliferator-activated receptor δ activation (English)

1 reference

Europe PubMed Central

30 November 2017

fatty liver disease

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

7

object named as

Bernd Nilius

1 reference

Europe PubMed Central

30 November 2017

author name string

Qiang Li

1

1 reference

Europe PubMed Central

30 November 2017

Li Li

2

1 reference

Europe PubMed Central

30 November 2017

Fei Wang

3

1 reference

Europe PubMed Central

30 November 2017

Jian Chen

4

1 reference

Europe PubMed Central

30 November 2017

Yu Zhao

5

1 reference

Europe PubMed Central

30 November 2017

Peijian Wang

6

1 reference

Europe PubMed Central

30 November 2017

Daoyan Liu

8

1 reference

Europe PubMed Central

30 November 2017

Zhiming Zhu

9

1 reference

Europe PubMed Central

30 November 2017

publication date

21 April 2013

1 reference

Europe PubMed Central

30 November 2017

Pfluegers Archiv

1 reference

Europe PubMed Central

30 November 2017

465

1 reference

Europe PubMed Central

30 November 2017

1303-1316

1 reference

Europe PubMed Central

30 November 2017

9

1 reference

Europe PubMed Central

30 November 2017

https://scigraph.springernature.com/pub.10.1007/s00424-013-1274-4

0 references

Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Autophagy in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Statins in liver disease: a molehill, an iceberg, or neither?

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Bile salt-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide as a hepatoprotective agent.

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Liver X Receptor: an oxysterol sensor and a major player in the control of lipogenesis.

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Mitochondria supply membranes for autophagosome biogenesis during starvation

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Thiazolidinedione therapy for nonalcoholic steatohepatitis: go, stop, or proceed with caution?

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Telmisartan prevents weight gain and obesity through activation of peroxisome proliferator-activated receptor-delta-dependent pathways

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger?

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Disruption of PPARgamma signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy.

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Autophagy in nuclear receptor PPARgamma-deficient mouse prostatic carcinogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

High expression of vanilloid receptor-1 is associated with better prognosis of patients with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Emerging molecular targets for the treatment of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

The transient receptor potential family of ion channels

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Transient receptor potential cation channels in disease

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Vanilloid transient receptor potential cation channels: an overview

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Dihydrocapsaicin (DHC), a saturated structural analog of capsaicin, induces autophagy in human cancer cells in a catalase-regulated manner

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Density functional computational studies on (E)-2-[(2-Hydroxy-5-nitrophenyl)-iminiomethyl]-4-nitrophenolate.

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob/ob mice

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Autophagy in liver diseases.

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Alteration of sphingolipid metabolism and pSTAT3 expression by dietary cholesterol in the gallbladder of hamsters

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Spider toxins activate the capsaicin receptor to produce inflammatory pain.

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Autophagy regulates lipid metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Roles of PPARs in NAFLD: potential therapeutic targets

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Nonalcoholic fatty liver disease: a challenge for pediatricians

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Prevention of free fatty acid-induced hepatic lipotoxicity by 18beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension.

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance.

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Nonalcoholic fatty liver disease and low-carbohydrate diets

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids

1 reference

https://api.crossref.org/works/10.1007%2FS00424-013-1274-4

21 January 2018

Lifestyle intervention and fatty liver disease: the importance of both disrupting inflammation and reducing visceral fat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23605066

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

1 reference

https://pubmed.ncbi.nlm.nih.gov/23605066

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TRPV1 activation prevents nonalcoholic fatty liver through UCP2 upregulation in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/23605066

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23605066

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet

1 reference

https://pubmed.ncbi.nlm.nih.gov/23605066

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00424-013-1274-4

1 reference

Europe PubMed Central

30 November 2017

1 reference

Europe PubMed Central

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44206097&oldid=2108518960"